Breast Cancer
Conditions
Interventions
control group:Health education and clinical intervention
Test group one:Health education and Huangqi Guizhi Wuwu decoction
Test group two:Health education and acupuncture treatment
Sponsors
National Cancer Center Chinese Academy of Medical Sciences / Cancer Hospital of Peking Union Medical College
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Patients with breast cancer confirmed by histology or pathology; 2) Age 18-70 years old; 3) Plan to receive or have received paclitaxel drugs: including paclitaxel docetaxel albumin Paclitaxel; 4) The estimated survival time is more than 3 months; 5) It conforms to the category of syndrome differentiation and treatment of blood stasis in traditional Chinese medicine; 6) Patients with good compliance; 7) The patient has no disturbance of consciousness and can communicate with normal language;
Exclusion criteria
Exclusion criteria: 1) Age 70 years old; 2) Peripheral neuropathy caused by other reasons; 3) There are heart liver and kidney dysfunction cardiovascular disease and endocrine disorders; Accompanied by mental and consciousness disorders; Serious skin disease and systemic infection; 4) The patient was involuntary.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0;European Organization for Research and Treatment of Cancer Quality of Life Questionnaire – Chemotherapy-Induced Peripheral Neuropathy Module (EORTC QLQ-CIPN20);Clinical Version of Total Neuropathy Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Psychological State Rating Scale;Syndrome Level Evaluation and Functional Index (SLEFI);European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30); | — |
Countries
China
Contacts
Public ContactZhaoFang
National Cancer CenterChinese Academy of Medical Sciences/Cancer Hospital of Peking Union Medical College
Outcome results
None listed